↓

Industry News – Multiple Sources

News from around the world

Industry News – Multiple Sources
Home Menu ↓
Skip to primary content
Skip to secondary content
  • Back to Main Site
  • News Page
  • News Sources
Home→Blog→acquisition→Sequenom’s CEO ‘Puzzled’ by Illumina’s Buy of Verinata, Lays out 2013 Goals at JP Morgan

Post navigation

← Studies Uncover Host Expression Signatures in Influenza, Bacterial Infections
JP Morgan Healthcare Conference, Day Three: Foundation Medicine, Luminex, PerkinElmer, Danaher, Quidel, Ariosa, BioFire, Atossa, Exact Sciences →

Sequenom’s CEO ‘Puzzled’ by Illumina’s Buy of Verinata, Lays out 2013 Goals at JP Morgan

Posted on January 10, 2013 by GenomeWeb Daily News

 

read more

This entry was posted in acquisition, Clinical Genomics, Harry Hixson, Illumina, JP Morgan Healthcare Conference, MaterniT21 Plus, noninvasive prenatal testing, Sequencing, Sequenom, trisomy, Verifi, Verinata by GenomeWeb Daily News. Bookmark the permalink.

Post navigation

← Studies Uncover Host Expression Signatures in Influenza, Bacterial Infections
JP Morgan Healthcare Conference, Day Three: Foundation Medicine, Luminex, PerkinElmer, Danaher, Quidel, Ariosa, BioFire, Atossa, Exact Sciences →

Leave a Reply Cancel reply

You must be logged in to post a comment.

Recent Posts

  • Karyopharm grabs $48M round for pipeline work
  • FDA bestows ‘Breakthrough Therapy’ status to drug for fatal infant disease
  • ICR, Wellcome Trust, Illumina Launch Clinical Genetic Testing Effort
  • Life Tech’s 3500 Sanger Sequencers Receive Regulatory Approval in Canada
  • PacBio Signs On Brazilian Distributor for PacBio RS II Platform

Recent Comments

  • admin on Deloitte Consulting Buys Analytics Firm Recombinant Data
  • jerseys low price on Researchers nab $11M to fund second look at AstraZeneca’s stockpile of failed drugs
  • nfl jerseys supply on Deloitte Consulting Buys Analytics Firm Recombinant Data

Archives

  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012

Categories

RSS GenomeWeb

  • ICR, Wellcome Trust, Illumina Launch Clinical Genetic Testing Effort May 20, 2013
      read more […]
  • Life Tech's 3500 Sanger Sequencers Receive Regulatory Approval in Canada May 20, 2013
      read more […]
  • PacBio Signs On Brazilian Distributor for PacBio RS II Platform May 20, 2013
      read more […]
  • Researchers Report on Mutational Patterns in Adenoid Cystic Carcinoma May 20, 2013
      read more […]
  • Genetic Technologies Signs on MultiPlan for Coverage of Breast Cancer Test May 20, 2013
      read more […]

RSS FierceBiotech

  • Karyopharm grabs $48M round for pipeline work May 20, 2013
  • FDA bestows 'Breakthrough Therapy' status to drug for fatal infant disease May 20, 2013
  • Pentagon adviser quietly pocketed biotech's cash while promoting its interests May 20, 2013
  • FDA: Merck's sleep drug suvorexant effective, but safety issues draw heavy flak May 20, 2013
  • XenoPort shares skid after MS drug proves to be a lemon in PhIII May 20, 2013

RSS Fierce Biomarkers

  • Genome mutations reveal acute myeloid leukemia risk, potential drug targets May 15, 2013
  • Blood protein could mark atherosclerosis May 15, 2013
  • Biomarker trio enables blood Dx to map heart attack risk May 15, 2013
© 2013 - Industry News – Multiple Sources Proudly powered by WordPress  Weaver II by WP Weaver
↑